44°F
weather icon Clear

Nevada official joins investigation of opioid epidemic

CARSON CITY — Nevada Attorney General Adam Laxalt said Thursday his office is investigating how companies may have contributed to the opioid epidemic.

The investigation is part of an effort involving a coalition of attorneys general from across the U.S. The scope of the investigation includes what role opioid manufacturers may have had in igniting or extending the epidemic, Laxalt’s office said.

“The national opioid epidemic has hit Nevada hard, and we have been investigating drug manufacturers for many months,” Laxalt said in a statement. “This is an important investigation on behalf of the health and safety of all Nevadans.”

Laxalt’s office did not specify a target but noted that the investigation includes subpoenaed records and interviews.

Senate Bill 59, which targets prescription painkiller abuse, was passed by the Legislature this session and signed into law by Gov. Brian Sandoval on May 30. It requires the reporting of controlled-substance violations, prescription drug-related overdoses and deaths, and stolen prescription drugs to the Prescription Monitoring Program.

The attorney general’s office reached a $5.3 million settlement with Volkswagon in 2016 over deceptive trade practices that gave him the discretion to use the money for education and enforcement efforts tied to opioid addiction and abuse.

Laxalt’s office gave no indication of how many states are involved in the coalition, which is bipartisan and involves a majority of attorneys general in the U.S.

The Idaho Attorney General’s Office and the California Department of Justice confirmed they are part of the coalition. A spokeswoman for Arizona Attorney General Mark Brnovich declined to say if the state is involved.

Contact Ben Botkin at bbotkin@reviewjournal.com or 775-461-0661. Follow @BenBotkin1 on Twitter.

Don't miss the big stories. Like us on Facebook.
THE LATEST
Lawsuit challenges Nevada’s new diabetes drug disclosure law

Two pharmaceutical groups have filed a lawsuit in federal court challenging the constitutionality of a bill passed by the 2017 Nevada Legislature requiring disclosure of the pricing of diabetes drugs.

Nevada Legislature approves final payment for ESA software

The final action on Nevada’s controversial private school choice program came Thursday when the Legislature’s Interim Finance Committee approved $105,000 to pay off the remaining costs incurred by a vendor who was working on the development of software to implement the program.

 
Recall targets a third Nevada senator

A third recall petition against a female Nevada state senator was filed Wednesday.

Federal government approves Nevada’s education plan

Nevada is among four states to get U.S. Education Department approval of its plan as required under a new federal education law, the Every Student Succeeds Act, or ESSA.